As for PD-L1 expression in tumor tissues, only one study reported higher PD-L1 expression as assessed by immunohistochemistry in patients with NSCLC and diabetes than in patients who did not have diabetes34. The gene discussed is CD274; the disease is non-small cell lung carcinoma.